• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床问卷在优化慢性阻塞性肺疾病日常护理中的作用。

Role of clinical questionnaires in optimizing everyday care of chronic obstructive pulmonary disease.

机构信息

Cardiac and Vascular Medicine, St George's, University of London, UK.

出版信息

Int J Chron Obstruct Pulmon Dis. 2011;6:289-96. doi: 10.2147/COPD.S18181. Epub 2011 May 26.

DOI:10.2147/COPD.S18181
PMID:21697993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3119104/
Abstract

Chronic obstructive pulmonary disease (COPD) is a leading cause of disability in all its stages, and death in patients with moderate or severe obstruction. At present, COPD is suboptimally managed; current health is often not measured properly and hardly taken into account in management plans, and the future risk for patients with regard to health status and quality of life is not being evaluated. This review addresses the effect of COPD on the lives of patients and examines ways in which existing assessment tools meet physicians' needs for a standardized, simple method to measure consistently the full impact of COPD on patients in routine clinical practice. Current assessment of COPD severity tends to focus on airflow limitation, but this does not capture the full impact of the disease and is not well correlated with patient perception of symptoms and health-related quality of life. Qualitative studies have demonstrated that patients usually consider COPD impact in terms of frequency and severity of symptoms, and physical and emotional wellbeing. However, patients often have difficulty expressing their disease burden and physicians generally have insufficient time to collect this information. Therefore, it is important that methods are implemented to help generate a more complete understanding of the impact of COPD. This can be achieved most efficiently using a quick, reliable, and standardized measure of disease impact, such as a short questionnaire that can be applied in daily clinical practice. Questionnaires are precision instruments that contribute sensitive and specific information, and can potentially help physicians provide optimal care for patients with COPD. Two short, easy-to-use, specific measures, ie, the COPD Assessment Test and the Clinical COPD Questionnaire, enable physicians to assess patients' health status accurately and improve disease management. Such questionnaires provide important measurements that can assist primary care physicians to capture the impact of COPD on patients' daily lives and wellbeing, and improve long-term COPD management.

摘要

慢性阻塞性肺疾病(COPD)是所有阶段导致残疾的主要原因,也是中重度阻塞患者死亡的主要原因。目前,COPD 的管理效果并不理想;当前的健康状况通常没有得到适当的衡量,在管理计划中几乎没有得到考虑,而且患者未来的健康状况和生活质量风险也没有得到评估。这篇综述探讨了 COPD 对患者生活的影响,并探讨了现有的评估工具如何满足医生的需求,即采用一种标准化、简单的方法,在常规临床实践中持续衡量 COPD 对患者的全面影响。目前对 COPD 严重程度的评估往往侧重于气流受限,但这并不能完全捕捉到疾病的影响,也与患者对症状和健康相关生活质量的感知相关性不佳。定性研究表明,患者通常根据症状的频率和严重程度以及身体和情绪健康来考虑 COPD 的影响。然而,患者通常难以表达他们的疾病负担,而医生通常没有足够的时间来收集这些信息。因此,实施有助于更全面了解 COPD 影响的方法非常重要。使用快速、可靠和标准化的疾病影响衡量方法,如可在日常临床实践中应用的简短问卷,最有效地实现这一目标。问卷是精密仪器,可提供敏感和具体的信息,并且可能有助于医生为 COPD 患者提供最佳护理。两种简短、易用、具体的措施,即 COPD 评估测试和临床 COPD 问卷,使医生能够准确评估患者的健康状况并改善疾病管理。这些问卷提供了重要的测量结果,可以帮助初级保健医生捕捉 COPD 对患者日常生活和幸福感的影响,并改善 COPD 的长期管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9528/3119104/bb87319cc3bd/copd-6-289f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9528/3119104/9a485b768849/copd-6-289f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9528/3119104/63a257db2971/copd-6-289f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9528/3119104/b78379b5d43c/copd-6-289f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9528/3119104/bb87319cc3bd/copd-6-289f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9528/3119104/9a485b768849/copd-6-289f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9528/3119104/63a257db2971/copd-6-289f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9528/3119104/b78379b5d43c/copd-6-289f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9528/3119104/bb87319cc3bd/copd-6-289f4.jpg

相似文献

1
Role of clinical questionnaires in optimizing everyday care of chronic obstructive pulmonary disease.临床问卷在优化慢性阻塞性肺疾病日常护理中的作用。
Int J Chron Obstruct Pulmon Dis. 2011;6:289-96. doi: 10.2147/COPD.S18181. Epub 2011 May 26.
2
COPD management: role of symptom assessment in routine clinical practice.COPD 管理:症状评估在常规临床实践中的作用。
Int J Chron Obstruct Pulmon Dis. 2013;8:461-71. doi: 10.2147/COPD.S49392. Epub 2013 Oct 14.
3
Canadian practice assessment in chronic obstructive pulmonary disease: respiratory specialist physician perception versus patient reality.加拿大慢性阻塞性肺疾病实践评估:呼吸专科医师的看法与患者的实际情况。
Can Respir J. 2013 Mar-Apr;20(2):97-105. doi: 10.1155/2013/369019.
4
Feasibility and applicability of the paper and electronic COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ) in primary care: a clinimetric study.纸质版和电子版慢性阻塞性肺疾病评估测试(CAT)和临床慢性阻塞性肺疾病问卷(CCQ)在初级保健中的可行性和适用性:一项临床测量研究。
NPJ Prim Care Respir Med. 2017 Mar 28;27(1):20. doi: 10.1038/s41533-017-0023-0.
5
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].[氯化乙酰甲胆碱支气管激发试验标准技术规范(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247.
6
C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT.C 反应蛋白即时检测用于安全减少慢性阻塞性肺疾病急性加重期抗生素使用的研究:PACE RCT。
Health Technol Assess. 2020 Mar;24(15):1-108. doi: 10.3310/hta24150.
7
Contemporary issues in the care of patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者护理中的当代问题。
J Manag Care Pharm. 2005 Jun;11(5 Suppl A):S2-13; quiz S14-6. doi: 10.18553/jmcp.2005.11.s5-a.1.
8
[Evaluation of therapy efficiency in patients with combined course of copd and osteoarthritis].[慢性阻塞性肺疾病与骨关节炎合并病程患者治疗效果评估]
Wiad Lek. 2016;69(2 Pt 2):214-8.
9
Guideline-based survey of outpatient COPD management by pulmonary specialists in Germany.德国肺病专家基于指南对门诊 COPD 管理的调查。
Int J Chron Obstruct Pulmon Dis. 2012;7:101-8. doi: 10.2147/COPD.S27887. Epub 2012 Feb 14.
10
The use of health status questionnaires in the management of chronic obstructive pulmonary disease patients in clinical practice.在临床实践中使用健康状况问卷管理慢性阻塞性肺疾病患者。
Expert Rev Respir Med. 2014 Aug;8(4):479-91. doi: 10.1586/17476348.2014.918851. Epub 2014 Jun 4.

引用本文的文献

1
CAD-Q (COPD-Asthma Differentiation Questionnaire): Performance of a new diagnostic score to differentiate between COPD and asthma in adults.CAD-Q(慢性阻塞性肺疾病-哮喘鉴别问卷):一种用于区分成人慢性阻塞性肺疾病和哮喘的新诊断评分方法的性能
BMC Pulm Med. 2025 Jan 15;25(1):20. doi: 10.1186/s12890-025-03492-5.
2
Informing community pharmacists on COPD case-finding methods: A scoping review.向社区药剂师介绍慢性阻塞性肺疾病(COPD)病例发现方法:一项范围综述。
Can Pharm J (Ott). 2024 Oct 15;157(6):290-303. doi: 10.1177/17151635241284802. eCollection 2024 Nov-Dec.
3
Breaking down barriers to COPD management in primary care: applying the updated 2023 Canadian Thoracic Society guideline for pharmacotherapy.

本文引用的文献

1
Disability in COPD and its relationship to clinical and patient-reported outcomes.COPD 中的残疾及其与临床和患者报告结局的关系。
Curr Med Res Opin. 2011 May;27(5):981-6. doi: 10.1185/03007995.2011.563285. Epub 2011 Mar 8.
2
Health-related quality of life in patients by COPD severity within primary care in Europe.欧洲初级保健中 COPD 严重程度与患者健康相关生活质量的关系。
Respir Med. 2011 Jan;105(1):57-66. doi: 10.1016/j.rmed.2010.09.004. Epub 2010 Oct 6.
3
Susceptibility to exacerbation in chronic obstructive pulmonary disease.
消除初级保健中慢性阻塞性肺疾病管理的障碍:应用2023年更新的加拿大胸科学会药物治疗指南
Front Med (Lausanne). 2024 Aug 6;11:1416163. doi: 10.3389/fmed.2024.1416163. eCollection 2024.
4
High burden of symptoms reported among patients diagnosed with chronic obstructive pulmonary disease (COPD) in Greenland after introducing the COPD Assessment Test in clinical practice.格陵兰在临床实践中引入 COPD 评估测试后,被诊断患有慢性阻塞性肺疾病(COPD)的患者报告了较高的症状负担。
Int J Circumpolar Health. 2023 Dec;82(1):2220476. doi: 10.1080/22423982.2023.2220476.
5
Validity of EQ-5D utility index and minimal clinically important difference estimation among patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的 EQ-5D 效用指数和最小临床重要差异的有效性评估。
BMC Pulm Med. 2020 Mar 23;20(1):73. doi: 10.1186/s12890-020-1116-z.
6
Comparison between electronic and paper versions of patient-reported outcome measures in subjects with chronic obstructive pulmonary disease: an observational study with a cross-over administration.电子版和纸质版患者报告结局测量在慢性阻塞性肺疾病患者中的比较:一项交叉管理的观察性研究。
BMJ Open. 2019 Dec 18;9(12):e032767. doi: 10.1136/bmjopen-2019-032767.
7
Clinical Development and Research Applications of the Chronic Obstructive Pulmonary Disease Assessment Test.慢性阻塞性肺疾病评估测试的临床开发与研究应用
Am J Respir Crit Care Med. 2020 May 1;201(9):1058-1067. doi: 10.1164/rccm.201907-1369PP.
8
Responsiveness of PROMIS® to change in chronic obstructive pulmonary disease.患者报告结果测量信息系统(PROMIS®)对慢性阻塞性肺疾病变化的反应性
J Patient Rep Outcomes. 2019 Oct 29;3(1):65. doi: 10.1186/s41687-019-0155-9.
9
Improvement in health status with once-daily indacaterol/glycopyrronium 110/50 μg in COPD patients: real-world evidence from an observational study in Ireland.在慢性阻塞性肺疾病(COPD)患者中,每日一次使用茚达特罗/格隆溴铵110/50μg可改善健康状况:来自爱尔兰一项观察性研究的真实世界证据。
Ir J Med Sci. 2019 Nov;188(4):1251-1259. doi: 10.1007/s11845-019-02001-y. Epub 2019 Mar 28.
10
Comparison of patient-reported outcomes during acute exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重期患者报告结局的比较
BMJ Open Respir Res. 2018 Oct 9;5(1):e000305. doi: 10.1136/bmjresp-2018-000305. eCollection 2018.
慢性阻塞性肺疾病恶化的易感性。
N Engl J Med. 2010 Sep 16;363(12):1128-38. doi: 10.1056/NEJMoa0909883.
4
Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index.慢性阻塞性肺疾病严重程度综合指数的推导和验证:DOSE 指数。
Am J Respir Crit Care Med. 2009 Dec 15;180(12):1189-95. doi: 10.1164/rccm.200902-0271OC. Epub 2009 Sep 24.
5
Development and first validation of the COPD Assessment Test.COPD 评估测试的制定与首次验证。
Eur Respir J. 2009 Sep;34(3):648-54. doi: 10.1183/09031936.00102509.
6
Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.噻托溴铵对中度慢性阻塞性肺疾病患者预后的影响(UPLIFT):一项随机对照试验的预设亚组分析
Lancet. 2009 Oct 3;374(9696):1171-8. doi: 10.1016/S0140-6736(09)61298-8. Epub 2009 Aug 27.
7
Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study.沙美特罗/丙酸氟替卡松治疗慢性阻塞性肺疾病不同GOLD分级的疗效:来自随机、安慰剂对照TORCH研究的分析
Respir Res. 2009 Jun 30;10(1):59. doi: 10.1186/1465-9921-10-59.
8
The Prevalence of chronic obstructive pulmonary disease among Danes aged 45-84 years: population-based study.45至84岁丹麦人群中慢性阻塞性肺疾病的患病率:基于人群的研究。
COPD. 2008 Dec;5(6):347-52. doi: 10.1080/15412550802522635.
9
Frequency of self-reported COPD exacerbation and airflow obstruction in five Latin American cities: the Proyecto Latinoamericano de Investigacion en Obstruccion Pulmonar (PLATINO) study.五个拉丁美洲城市自我报告的慢性阻塞性肺疾病加重和气流受限的频率:拉丁美洲肺阻塞性疾病研究项目(PLATINO)研究
Chest. 2009 Jul;136(1):71-78. doi: 10.1378/chest.08-2081. Epub 2009 Apr 6.
10
Validation of the clinical COPD Questionnaire (CCQ) in primary care.基层医疗中慢性阻塞性肺疾病临床问卷(CCQ)的验证
Health Qual Life Outcomes. 2009 Mar 25;7:26. doi: 10.1186/1477-7525-7-26.